To verify the role of CXCR4 and CD133 in ovarian cancer patients, CXCR4, CD133, CD44, CD24 were evaluated in 37 surgically resected primary ovarian epithelial tumors (Table 2). The gene discussed is CD24; the disease is ovarian epithelial tumor.